Stay updated on Durvalumab Combo + Maintenance in Advanced Ovarian Cancer Clinical Trial
Sign up to get notified when there's something new on the Durvalumab Combo + Maintenance in Advanced Ovarian Cancer Clinical Trial page.

Latest updates to the Durvalumab Combo + Maintenance in Advanced Ovarian Cancer Clinical Trial page
- CheckyesterdayChange DetectedThe page now shows Revision: v3.6.6, updating from Revision: v3.6.5 to reflect a newer system release.SummaryDifference0.0%

- Check8 days agoChange DetectedThe NIH funding line now includes the year 2017 (U.S. NIH Grant/Contract) in the study's identifiers. This clarifies the funding source associated with the trial.SummaryDifference0.0%

- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedRevision: v3.6.5 was added to the page’s revision history and Revision: v3.6.4 was removed, updating the version information reflected on the page.SummaryDifference0.0%

- Check29 days agoChange DetectedThe Study Documents section now omits several PDFs and references (CSR synopsis, SAP, CSP, IPD Sharing information, and related disclosures). This change removes access to key study documentation and data-sharing commitments, altering how users can review the trial's protocol and results materials.SummaryDifference17%

- Check44 days agoChange DetectedThe page's revision tag was updated to v3.6.4 from v3.6.3, indicating a minor metadata update to the study record. This does not change any study details or user-facing content presented on the page.SummaryDifference0.0%

- Check51 days agoChange DetectedJuly 2026 update timestamps were added to the study record and older May–June entries were removed from the update history, reflecting routine administrative maintenance of the page.SummaryDifference0.1%

Stay in the know with updates to Durvalumab Combo + Maintenance in Advanced Ovarian Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Durvalumab Combo + Maintenance in Advanced Ovarian Cancer Clinical Trial page.